Cargando…

A Mobile Health Strategy to Support Adherence to Antiretroviral Preexposure Prophylaxis

Preexposure prophylaxis is a highly protective HIV prevention strategy, yet nonadherence can significantly reduce its effectiveness. We conducted a mixed methods evaluation of a mobile health intervention (iText) that utilized weekly bidirectional text or e-mail support messages to encourage preexpo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuchs, Jonathan D., Stojanovski, Kristefer, Vittinghoff, Eric, McMahan, Vanessa M., Hosek, Sybill G., Amico, K. Rivet, Kouyate, Aminta, Gilmore, Hailey J., Buchbinder, Susan P., Lester, Richard T., Grant, Robert M., Liu, Albert Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2018
Materias:	Clinical and Epidemiologic Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865612/ https://www.ncbi.nlm.nih.gov/pubmed/29565183 http://dx.doi.org/10.1089/apc.2017.0255

Ejemplares similares

Randomized Controlled Trial of a Mobile Health Intervention to Promote Retention and Adherence to Preexposure Prophylaxis Among Young People at Risk for Human Immunodeficiency Virus: The EPIC Study
por: Liu, Albert Y, et al.
Publicado: (2019)

Adherence to Preexposure Prophylaxis: Current, Emerging, and Anticipated Bases of Evidence
por: Amico, K. Rivet, et al.
Publicado: (2014)

No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis
por: Marcus, Julia L., et al.
Publicado: (2013)

In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?
por: Mitchell, Kate M., et al.
Publicado: (2018)

Oral preexposure prophylaxis continuation, measurement and reporting
por: Stankevitz, Kayla, et al.
Publicado: (2020)

Effectiveness and safety of oral HIV preexposure prophylaxis for all populations
por: Fonner, Virginia A., et al.
Publicado: (2016)

The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion
por: Donnell, Deborah, et al.
Publicado: (2017)

Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV
por: Nguyen, Vinh-Kim, et al.
Publicado: (2018)

HIV-1 Drug Resistance in the iPrEx Preexposure Prophylaxis Trial
por: Liegler, Teri, et al.
Publicado: (2014)

Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States
por: Aaron, Erika, et al.
Publicado: (2018)

Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM
por: Estcourt, Claudia, et al.
Publicado: (2021)

Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisition
por: Fonner, Virginia A., et al.
Publicado: (2023)

Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis
por: Tseng, Chien-Wen, et al.
Publicado: (2020)

Preexposure prophylaxis strategies for African–American women affected by mass incarceration
por: Adams, Joëlla W., et al.
Publicado: (2021)

Elimination prospects of the Dutch HIV epidemic among men who have sex with men in the era of preexposure prophylaxis
por: Rozhnova, Ganna, et al.
Publicado: (2018)

The European preexposure prophylaxis revolution
por: Cairns, Gus, et al.
Publicado: (2016)

Transient Changes in Preexposure Prophylaxis Use and Daily Sexual Behavior After the Implementation of COVID-19 Restrictions Among Men Who Have Sex With Men
por: Jongen, Vita W., et al.
Publicado: (2021)

Eligibility for HIV Preexposure Prophylaxis, Intention to Use Preexposure Prophylaxis, and Informal Use of Preexposure Prophylaxis Among Men Who Have Sex With Men in Amsterdam, the Netherlands
por: Hulstein, Sebastiaan H., et al.
Publicado: (2021)

The use of preexposure treatments for HIV prophylaxis
por: Majid, Adrian, et al.
Publicado: (2012)

Statistical issues in trials of preexposure prophylaxis
por: Dunn, David T., et al.
Publicado: (2016)

Syphilis Predicts HIV Incidence Among Men and Transgender Women Who Have Sex With Men in a Preexposure Prophylaxis Trial
por: Solomon, Marc M., et al.
Publicado: (2014)

Missed Visits Associated With Future Preexposure Prophylaxis (PrEP) Discontinuation Among PrEP Users in a Municipal Primary Care Health Network
por: Spinelli, Matthew A, et al.
Publicado: (2019)

Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence – a narrative review
por: Haire, Bridget G
Publicado: (2015)

Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men
por: Hoenigl, Martin, et al.
Publicado: (2018)

Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women
por: Anderson, Peter L., et al.
Publicado: (2016)

Daily Oral Emtricitabine/Tenofovir Preexposure Prophylaxis and Herpes Simplex Virus Type 2 among Men Who Have Sex with Men
por: Marcus, Julia L., et al.
Publicado: (2014)

Strong Relationship between Oral Dose and Tenofovir Hair Levels in a Randomized Trial: Hair as a Potential Adherence Measure for Pre-Exposure Prophylaxis (PrEP)
por: Liu, Albert Y., et al.
Publicado: (2014)

Multicompartmental pharmacokinetic evaluation of long‐acting cabotegravir in healthy adults for HIV preexposure prophylaxis
por: Shaik, Jafar Sadik, et al.
Publicado: (2021)

P41 - Preexposure prophylaxis of infants’ food allergy
por: Denisova, Svetlana, et al.
Publicado: (2014)

Stigmatizing Policies Interact with Mental Health and Sexual Behaviours to Structurally Induce HIV Diagnoses Among European Men Who Have Sex with Men
por: Stojanovski, Kristefer, et al.
Publicado: (2022)

Correction to: Stigmatizing Policies Interact with Mental Health and Sexual Behaviours to Structurally Induce HIV Diagnoses Among European Men Who Have Sex with Men
por: Stojanovski, Kristefer, et al.
Publicado: (2022)

Effect of 6-Month HIV Preexposure Prophylaxis Dispensing With Interim Self-testing on Preexposure Prophylaxis Continuation at 12 Months: A Randomized Noninferiority Trial
por: Ortblad, Katrina F., et al.
Publicado: (2023)

Feasibility, Acceptability, and Adherence with Short-Term HIV Preexposure Prophylaxis in Female Sexual Partners of Migrant Miners in Mozambique
por: Lahuerta, Maria, et al.
Publicado: (2017)

Tenofovir-Diphosphate in Dried Blood Spots vs Tenofovir in Urine/Plasma for Oral Preexposure Prophylaxis Adherence Monitoring
por: Niu, Xin, et al.
Publicado: (2022)

Weighing the Risk of Drug Resistance With the Benefits of HIV Preexposure Prophylaxis
por: Grant, Robert M., et al.
Publicado: (2015)

Preexposure Prophylaxis for the Prevention of HIV Infection — 2014 Available Online
Publicado: (2014)

HIV Preexposure Prophylaxis in the U.S. Military Services — 2014–2016
por: Blaylock, Jason M., et al.
Publicado: (2018)

Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19
por: Kulkarni, Chanda, et al.
Publicado: (2021)

Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada
por: Knox, David C., et al.
Publicado: (2022)

High Medication Adherence During Periconception Periods Among HIV-1–Uninfected Women Participating in a Clinical Trial of Antiretroviral Pre-exposure Prophylaxis
por: Matthews, Lynn T., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gu9khk3dtc6l19g8hr6qm534ea